TerminatedNCT00746252
Side Effect Study of Antipsychotic Medicines to Treat Childhood Bipolarity
Medication studyAges 7–12United States
Understand this study
Who could participate?
Listed age limits: 7 years to 12 years.
- Listed locations
- BaltimoreSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateJune 2008
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 5
- Sponsor
- University of Maryland, Baltimore
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Locations
- United States
- Age range
- From 7 Years to 12 Years
- Official registry ID
- NCT00746252
- Official title
Show the full official title
Investigating Metabolic Side Effects of Antipsychotic Medications in Children
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Baltimore
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Maryland, Baltimore, a university.
Does this study involve medication?
Yes. The study involves medication, including risperidone and aripiprazole.
Who can participate?
Listed age limits: 7 years to 12 years.
Is this study still recruiting?
The registry lists this study as terminated.
Want to explore more studies?
Explore studiesRelated studies
16-week Comparative Effectiveness Trial of Lamotrigine vs. Fluoxetine for Depression in bipolarity
A Clinical Study of an Investigational Drug for the Treatment of Major Depressive Episode Associated With Bipolarity type I.